Cargando…

Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study

BACKGROUND: China’s Fujian Cervical Pilot Project (FCPP) transitioned cervical cancer screening from high-risk human papillomavirus (HR-HPV) nongenotyping to genotyping. We investigated the clinical impact of this introduction, comparing performance indicators between HR-HPV genotyping combined with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Binhua, Zou, Huachun, Mao, Xiaodan, Su, Yingying, Gao, Hangjing, Xie, Fang, Lv, Yuchun, Chen, Yaojia, Kang, Yafang, Xue, Huifeng, Pan, Diling, Sun, Pengming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107662/ https://www.ncbi.nlm.nih.gov/pubmed/33995595 http://dx.doi.org/10.1177/17588359211010939

Ejemplares similares

The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China
por: Pan, Diling, et al.
Publicado: (2020)

Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study
por: Dong, Binhua, et al.
Publicado: (2020)

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results
por: Xue, Huifeng, et al.
Publicado: (2021)

PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort
por: Kang, Yafang, et al.
Publicado: (2018)

HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
por: Chen, Lihua, et al.
Publicado: (2020)

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
por: Ruan, Guanyu, et al.
Publicado: (2018)

Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study
por: Sun, Pengming, et al.
Publicado: (2017)

Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case– control study
por: Dong, Binhua, et al.
Publicado: (2018)

Prevalence of Human Papillomavirus and Genotype Distribution in Pregnant and Non-Pregnant Women in China
por: Luo, Dandan, et al.
Publicado: (2021)

The prevalence of human papillomavirus and bacterial vaginosis among young women in China: a cross-sectional study
por: Lin, Wenyu, et al.
Publicado: (2021)

Peripheral blood lymphocytes influence human papillomavirus infection and clearance: a retrospective cohort study
por: Li, Ye, et al.
Publicado: (2023)

Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis
por: Lin, Wenyu, et al.
Publicado: (2022)

Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions
por: Zhong, Hui, et al.
Publicado: (2020)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China
por: Wang, Shizhuo, et al.
Publicado: (2012)

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
por: Huh, Warner K., et al.
Publicado: (2014)

Clinical validation of the Cervista(®) high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
por: Mao, Xiaodan, et al.
Publicado: (2018)

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan
por: Onuki, Mamiko, et al.
Publicado: (2020)

Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review
por: Bonde, Jesper H., et al.
Publicado: (2019)

Cervical Lesion Classification Method Based on Cross-Validation Decision Fusion Method of Vision Transformer and DenseNet
por: Li, Ping, et al.
Publicado: (2022)

Prevalence of human papillomavirus infection and genotyping for population-based cervical screening in developed regions in China
por: Zhang, Yanru, et al.
Publicado: (2016)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China
por: Zhang, Qiaoyu, et al.
Publicado: (2020)

Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana
por: Nartey, Yvonne, et al.
Publicado: (2023)

Cervical Human Papillomavirus Screening among Older Women
por: Grainge, Matthew J., et al.
Publicado: (2005)

Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
por: Kantathavorn, Nuttavut, et al.
Publicado: (2015)

Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016
por: Ouh, Yung-Taek, et al.
Publicado: (2018)

16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2019)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
por: Ogilvie, Gina S., et al.
Publicado: (2016)

The Role of Obstetric Factors, miRNA-30d and miRNA-181a in Postpartum Women with Pelvic Organ Prolapse
por: Lin, Wenyu, et al.
Publicado: (2020)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
por: Kim, Mee-seon, et al.
Publicado: (2020)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Low Red Blood Cell Count as an Early Indicator for Myometrial Invasion in Women with Endometrioid Endometrial Carcinoma with Metabolic Syndrome
por: Tong, Yao, et al.
Publicado: (2020)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping
por: Padhy, Radha Rani, et al.
Publicado: (2020)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

Distribution of human papillomavirus genotypes in cervical lesions
por: Ma, Li, et al.
Publicado: (2017)

Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France
por: Heard, Isabelle, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qrtralcqvu50238pn1jigfsvqr